cetirizine has been researched along with Palmoplantaris Pustulosis in 7 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomized, double-blind, placebo-controlled trial, patients with psoriasis with a Psoriasis Area and Severity Index ≥ 10 starting an FAE up to a dose of dimethylfumarate 720 mg per day were randomized 1 : 1 to receive either additional cetirizine 10 mg once daily (n = 25) or placebo (n = 25) for 12 weeks." | 5.20 | Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial. ( Balak, DM; Fallah-Arani, S; Neumann, HA; Thio, HB; Venema, CM, 2015) |
| "This open clinical trial suggests that cetirizine could be effective in treating psoriasis: (1) for its symptomatic control on itching; (2) for its immunopharmacologic modulation of leukocyte integrins and on the immunophenotype pattern of infiltrating and resident cells, and (3) for contributing to the clearing of the lesions clinically." | 5.08 | Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions. ( Caproni, M; Falcos, D; Lotti, T; Palleschi, GM; Papi, C, 1995) |
| "Cetirizine is a nonsedating, selective H1-receptor antagonist, whose therapeutic efficacy is probably the result of its effect on both the immediate allergic reaction and the late-phase allergic response." | 2.71 | Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients. ( Caproni, M; Fabbri, P; Floriani, I; Pestelli, E, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Mueller, SM | 2 |
| Navarini, AA | 2 |
| Goldust, M | 2 |
| Brandt, O | 2 |
| Griffiths, CEM | 2 |
| Kleyn, CE | 2 |
| Balak, DM | 1 |
| Fallah-Arani, S | 1 |
| Venema, CM | 1 |
| Neumann, HA | 1 |
| Thio, HB | 1 |
| Li, JH | 1 |
| Wang, ZF | 1 |
| Xie, YM | 1 |
| Zhao, W | 1 |
| Pestelli, E | 2 |
| Floriani, I | 2 |
| Fabbri, P | 2 |
| Caproni, M | 3 |
| Palleschi, GM | 1 |
| Falcos, D | 1 |
| Papi, C | 1 |
| Lotti, T | 1 |
| Giomi, B | 1 |
| Volpi, W | 1 |
| Spallanzani, A | 1 |
| Cardinali, C | 1 |
4 trials available for cetirizine and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial.
Topics: Administration, Oral; Adult; Cetirizine; Dermatologic Agents; Double-Blind Method; Drug Therapy, Com | 2015 |
Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients.
Topics: Adult; Aged; Cell Adhesion Molecules; Cetirizine; Double-Blind Method; E-Selectin; Female; Histamine | 2003 |
Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions.
Topics: Administration, Oral; Adult; Biopsy; Cell Adhesion Molecules; Cetirizine; Histamine H1 Antagonists; | 1995 |
Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study.
Topics: Adult; Aged; Anti-Allergic Agents; Cell Count; Cetirizine; Double-Blind Method; Female; Histamine H1 | 2001 |
3 other studies available for cetirizine and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Levocetirizine for the treatment of itch in psoriasis patients: An open-label pilot study in a real-world setting.
Topics: Adult; Cetirizine; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists, Non-Sedating; | 2020 |
The short-term effect of levocetirizine on quality of life, stress, and depression in itchy psoriasis patients.
Topics: Adult; Cetirizine; Depression; Histamine H1 Antagonists, Non-Sedating; Humans; Middle Aged; Pruritus | 2020 |
[Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database].
Topics: Adolescent; Adult; Aged; Ascorbic Acid; Calcium Gluconate; Cetirizine; China; Drugs, Chinese Herbal; | 2014 |